Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
D-Fibroheal Microgras is a silk protein-based antimicrobial gauze dressing developed by Fibroheal Woundcare. It is a non-adherent primary dressing impregnated with silk protein and nano silver (silver nanoparticles). The silk protein component is designed to facilitate optimal moisture retention and promote a regenerative environment for faster wound healing, while the nano silver provides broad-spectrum antimicrobial protection to maintain a microbe-free environment. It is specifically indicated for low to moderately exuding wounds, including minor burns, infection-prone donor sites, and wounds in anatomically difficult areas such as joints and curved surfaces.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on D-Fibroheal Microgras.